Concepedia
8
Publications
246
Citations
H-Index
2009
Active since
Affiliations
Erasmus MC(Current)
Erasmus University Rotterdam
Copenhagen University Hospital
Kirsten Rozemeijer is an author at Erasmus MC.
Publications per year
2009–2017
Comparing SurePath, ThinPrep, and conventional cytology as primary test method: SurePath is associated with increased CIN II+ detection rates
Kirsten Rozemeijer, Corine Penning, Albert G. Siebers et al. · Cancer Causes & Control · 2015 · 61 citations · Full text
Offering Self-Sampling to Non-Attendees of Organized Primary HPV Screening: When Do Harms Outweigh the Benefits?
Kirsten Rozemeijer, Inge M.C.M. de Kok, Steffie K. Naber et al. · Cancer Epidemiology Biomarkers & Prevention · 2014 · 49 citations · Full text
Cervical Cancer Screening in Partly HPV Vaccinated Cohorts – A Cost-Effectiveness Analysis
Steffie K. Naber, Suzette M. Matthijsse, Kirsten Rozemeijer et al. · PLoS ONE · 2016 · 40 citations · Full text
Cervical cancer incidence after normal cytological sample in routine screening using SurePath, ThinPrep, and conventional cytology: population based study
Kirsten Rozemeijer, Steffie K. Naber, Corine Penning et al. · BMJ · 2017 · 33 citations · Full text
Cervical histology after routine ThinPrep or SurePath liquid-based cytology and computer-assisted reading in Denmark
Matejka Rebolj, Johanne Rask, Marjolein van Ballegooijen et al. · British Journal of Cancer · 2015 · 23 citations · Full text
Rows per page
1–5 of 8